Yilian Launches Chronic Disease Management Platform 2.0 with Enhanced Patient-Centric Group Services

VCBeat (WeChat ID: vcbeat) has learned that on January 21, 2020, Medlinker officially launched version 2.0 of its Chronic Disease Management Platform. The platform upgrade primarily features enhanced management of patient-specific groups, optimization of the artificial intelligence knowledge base, and customization of chronic disease management service packages, aiming to provide more convenient and accessible chronic disease management services for both patients and physicians.

Population aging and the increasing prevalence of chronic diseases among younger populations are two major trends that cannot be ignored in today’s society. Against this backdrop, chronic diseases are increasingly affecting people’s daily lives. Meanwhile, with technological advancements, more conditions—such as cancer and HIV/AIDS—are now categorized within the realm of preventable, controllable, and manageable chronic diseases. Consequently, improving the quality of life for patients with chronic diseases and enabling physicians to better manage these patients have become key focal points for healthcare enterprises and institutions.

According to relevant officials at Medlinker, the most significant highlight of the upgraded Medlinker Chronic Disease Management Platform 2.0 is the implementation of a dedicated multi-to-one group-based chronic disease management service for patients. Unlike the previous one-on-one communication model between patients and physicians, which often resulted in delayed or missed responses due to physicians’ heavy workloads, while an excessive volume of simultaneous inquiries from patients could disrupt their normal workflow, the new model addresses these inefficiencies.

Therefore, addressing this issue, Medlinker has innovatively launched a multi-to-one exclusive group-based chronic disease management service. Upon initiating a chronic disease consultation, patients are added to a dedicated health group named after them. This group includes multiple roles—such as physicians, medical assistants, nutritionists, and AI assistants—who collaboratively participate in the patient’s health management. Patient inquiries and conditions are managed through a tiered approach: basic or simple questions are initially addressed by medical assistants, AI assistants, and dedicated nutritionists, while more complex medical issues are handled by physicians. This exclusive service model not only enhances the patient experience but also saves significant time for physicians, thereby improving the overall efficiency of the chronic disease management process. Additionally, the platform’s 2.0 version has optimized and accelerated customer service response times, ensuring that patients receive rapid responses to their consultations on the Medlinker platform.

Medlinker has currently launched chronic disease management services in multiple fields, including liver disease, diabetes, HIV, kidney disease, oncology, cardiovascular diseases, respiratory asthma, psychiatry, and pediatric ADHD-related conditions. It also provides corresponding chronic disease management service packages for patients to choose from according to their needs.

For patients with diabetes, supported by the service package, they can enjoy an efficient, closed-loop management process featuring “AI-assisted diagnosis and treatment, along with standardized professional health guidance on diet, exercise, lifestyle habits, and psychological well-being.” This approach helps patients establish healthy and orderly lifestyles, achieve blood glucose control targets, and prevent complications. After consultations, physicians issue electronic prescriptions online, enabling patients to purchase medications online and benefit from home delivery services. This management model has received positive feedback from diabetic patients on the platform. In the field of chronic cancer care, Medlinker’s oncology nutrition service package has also gained popularity among patients, achieving a repurchase rate of 86%.

Furthermore, this management approach enables the collection of comprehensive patient treatment data, which can be provided to physicians for academic research, thereby further advancing the quality of chronic disease management.

Moreover, not long ago, Medlinker, a leading chronic disease management platform in China, convened the 2019 Medlinker Physician Annual Conference and Chronic Disease Project Launch under the theme “Focusing on Chronic Diseases: With You on the Medical Journey.” Clinical experts and scholars from various fields, renowned domestic and international pharmaceutical companies, and prominent investors from well-known investment institutions attended the event to jointly witness the launch of Medlinker’s new platform and initiatives in the field of chronic disease management. Since early 2018, Medlinker has been strategically developing its internet hospital business, characterized by specialized chronic disease management. The platform closely connects doctors with patients, leveraging a “strong doctor-patient relationship chain” and adhering to the principle of being “patient-centered,” to continuously provide professional medical and humanistic care services to patients with specialized chronic conditions.

Regarding the trend of managing chronic diseases through internet-based approaches, Professor Li Zaicun, Chief Physician at Beijing Youan Hospital Affiliated to Capital Medical University, stated, “Taking HIV/AIDS as an example, a major reason for public panic in the past was insufficient understanding of the disease and limited channels for consultation. Later, due to social stigma, many patients were reluctant to proactively seek testing at offline medical institutions, fearing judgmental stares.”

“However, with the advent of internet-based solutions, patients can now engage in a series of consultations and self-monitoring activities on specialized chronic disease management platforms such as Medlinker. This approach not only ensures privacy but also provides compassionate care, alleviating patients’ fear and anxiety, and even increasing the rate of proactive screening among high-risk populations. I believe this is highly significant.”

“Internet + Chronic Disease Management” has been widely recognized by the public as an effective supplementary approach to out-of-hospital treatment, with significant untapped potential in both market size and demand. In this regard, Wang Shirui, Founder and CEO of Medlinker, stated, “Driven by advanced technologies and national policies, the transition of many diseases into chronic conditions is a positive development, as it means that more patients have survival opportunities after diagnosis. However, as we enter the era of ‘living with disease,’ how to effectively manage these conditions and improve patients’ quality of life has become an urgent issue facing both society and enterprises—a question that Medlinker has long been contemplating.”

“In the future, Medlinker will continuously upgrade and iterate on its existing research in chronic disease management, deepen its engagement in this field, and pioneer a new model of chronic disease management for the internet era. By setting an industry benchmark, Medlinker aims to provide doctors and patients with smarter, higher-quality, comprehensive, efficient, and convenient medical services for chronic disease management.”